ANKRD26 and myelodysplastic syndrome: RUNX1 mutations are associated with familial platelet disorder (FPD) with a predisposition to AML [157,161,162,163,164], while ANKRD26 and ETV6 mutations are associated with inherited thrombocytopenia and a predisposition to developing MDS and AML [162,165,166].